Brightsens Diagnostics supports SFNano 2022 !   The current molecular diagnostics techniques based on PCR are relatively slow, expensive and require qualified personnel, which make them incompatible with point-of-care testing. BrightSens Diagnostics develops point-of-care tests for screening, diagnostics, and follow-up of patients – easy to use, fast, economic and ecologic. Our patented technology based on […]